01 11AstraZeneca Canada Inc.
02 3Bausch Health, Canada Inc.
03 18Belmore Neidrauer LLP
04 63Boehringer Ingelheim (Canada) Ltd.
05 14GlaxoSmithKline Inc.
06 7McCarthy Tétrault LLP
07 15Merck Canada Inc.
08 9Smart & Biggar
09 16Blake Cassels & Graydon LLP
01 51328452
02 52143849
03 12290624
04 42294582
05 22388818
06 32402894
07 12412671
08 32435730
09 62450740
10 12476496
11 22486539
12 32496249
13 62529400
14 102534024
15 62536251
16 62557801
17 32559302
18 62606650
19 32622608
20 32651019
21 22653344
22 102671357
23 32694620
24 32720450
25 42733795
26 32738367
27 62752435
28 32752437
29 102767811
30 62776288
31 32776296
32 22780941
33 32782179
34 42799204
35 62813661
36 32875706
37 62908635
01 9ALOGLIPTIN BENZOATE | METFORMIN HYDROCHLORIDE
02 22CANAGLIFLOZIN | METFORMIN HYDROCHLORIDE
03 8DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE | METFORMIN HYDROCHLORIDE
04 36EMPAGLIFLOZIN | METFORMIN HYDROCHLORIDE
05 4ERTUGLIFLOZIN | METFORMIN HYDROCHLORIDE
06 27Linagliptin | Metformin Hydrochloride
07 12METFORMIN HYDROCHLORIDE | CANAGLIFLOZIN
08 3Metformin Hydrochloride
09 14Rosiglitazone Maleate and Metformin Hydrochloride
10 3Saxagliptin Hydrochloride | Metformin Hydrochloride
11 18sitagliptin phosphate monohydrate | metformin hydrochloride
01 69TABLET
02 25TABLET (EXTENDED-RELEASE)
03 6TABLET (IMMEDIATE RELEASE)
04 55Tablet
05 1Tablet (Extended-Release)
01 52011-04-12
02 52013-09-01
03 12018-06-05
04 42018-06-15
05 22020-10-02
06 12021-02-26
07 32021-03-05
08 32022-02-21
09 62022-07-05
10 12023-02-21
11 22023-05-15
12 32023-08-18
13 62024-06-18
14 102024-07-30
15 62024-08-27
16 32024-12-15
17 62025-03-11
18 62026-05-02
19 32026-09-13
20 62027-05-03
21 22027-06-21
22 102027-12-03
23 32028-07-16
24 32029-04-02
25 42029-08-17
26 32029-10-15
27 62030-02-11
28 32030-02-12
29 102030-07-07
30 92030-10-01
31 22030-11-12
32 32030-11-26
33 42031-05-11
34 62031-11-07
35 62034-04-03
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Saxagliptin Hydrochloride, Metformin Hydrochloride
Brand Name : KOMBOGLYZE
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg / 850 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Saxagliptin Hydrochloride, Metformin Hydrochloride
Brand Name : KOMBOGLYZE
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg / 500 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Saxagliptin Hydrochloride, Metformin Hydrochloride
Brand Name : KOMBOGLYZE
Patent Number : 2402894
Filing Date : 2001-03-05
Strength per Unit : 2.5 mg / 1000 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2021-03-05
Date Granted : 2012-04-17
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2653344
Filing Date : 2007-06-21
Strength per Unit : 5 mg / 850 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2388818
Filing Date : 2000-10-02
Strength per Unit : 5 mg / 850 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2486539
Filing Date : 2003-05-15
Strength per Unit : 5 mg / 850 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2653344
Filing Date : 2007-06-21
Strength per Unit : 5 mg / 1000 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-21
Date Granted : 2016-06-07
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2486539
Filing Date : 2003-05-15
Strength per Unit : 5 mg / 1000 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-15
Date Granted : 2012-03-13
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE
Brand Name : XIGDUO
Patent Number : 2388818
Filing Date : 2000-10-02
Strength per Unit : 5 mg / 1000 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2020-10-02
Date Granted : 2012-07-03
Patent Expiration Date : 2018-06-05
Date Granted : 2006-12-05
Brand Name : GLUMETZA
Patent Number : 2290624
Filing Date : 1998-06-05
Strength per Unit : 500mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-05
Date Granted : 2006-12-05
